2017 ReviewYear ended March 2017

Scroll to learn more

Meiji's Business

The Meiji Group provides customers of all ages ―from infants to seniors― with a wide range of products for healthy and fulfilling lives. From delicious confectionaries and wholesome dairy products to body-enhancing nutrition supplements and vital pharmaceuticals, we make people's wellness our main mission.

Meiji's Business

Key Figures

Net Sales
¥1,242.4 billion
1.5%
Operating Income Ratio
7.1 %
0.7 percentage points
Capital Expenditures
¥50.4 billion
Operating Income
¥88.3 billion
13.6%
ROE
14.2 %
1.9 percentage points
R&D Expenses
¥26.1 billion

Breakdown by Segment

Breakdown by Segment

Business Performance Analysis

Food

Net Sales
¥1,082.1 billion
2.0%
Operating Income
¥82.9 billion
21.5%

Income Analysis

Pharmaceuticals

Net Sales
¥161.6 billion
1.8%
Operating Income
¥5.7 billion
42.9%

Income Analysis

Capital Expenditures

Capital Expenditures

Food

¥44.3 billion

Pharmaceuticals

¥6.0 billion

Cash Dividends per Share / Dividend Payout Ratio

Dividend Payout Ratio / Cash Dividends per Share

Future Prospects

For the Third year of our STEP UP 17 initiative in FYE March 2018,
our consolidated earnings forecast is as follows:

FYE 3/2017
Results
Net sales ¥1,242.4 billion
Operating income ¥88.3 billion
Operating income ratio 7.1%
ROE 14.2%

FYE 3/2018
Targets
¥1,261.0 billion
¥94.5 billion
7.5%
14.2%

(as of May 12, 2017)